The Carbontech Development Initiative is pleased to announce awards of over $3 million to research and commercialization teams working to develop and scale critical negative emissions technologies.
CTV has partnered with Beiersdorf to launch the Beiersdorf & Columbia Skin Science Collaboration focused on identifying and supporting projects with the objective of developing novel in vitro skin models, validating dermatological targets, and identifying dermato-cosmetic compounds for inclusion in Beiersdorf’s over-the-counter brands.
Heirloom, which uses technology developed by Columbia's Dr. Peter Kelemen, closed a $150M Series B round.
MBF Bioscience announced the launch of SLICE, invented by Columbia's Dr. Raju Tomer and Dr. Lars Dietrich, at the Society for Neuroscience meeting. SLICE is a paradigm shift in light-sheet microscopy that combines high performance with unprecedented affordability and a compact device footprint.
A Columbia Engineering startup nabs $44M to tackle energy and scalability challenges with a new platform that significantly boosts AI data performance and efficiency.
Columbia ranked fifth in Inc. Magazine and Fast Company's list of top 50 institutions revolutionizing entrepreneurship.
Columbia's Dr. Carol Troy was the winner of a 2024 XSeed Award. She received a $250K grant for her work to develop the first noninvasive treatment for retinal vascular occlusion.
Columbia's Dr. Gary W. Miller and Dr. David Sulzer were selected for the 2024 SPARK NS Parkinson’s Disease Translational Research Program, a two-year immersive program designed to advance academic discoveries in Parkinson’s disease from the lab to the clinic.
Columbia's Dr. Andrew Wang was featured in Chemical & Engineering News for applying his research to build a startup that could transform the future of energy storage. His company, Standard Potential, is commercializing a sodium-ion battery technology designed to reduce the cost of batteries.
Sable Therapeutics announced an exclusive license from Columbia for a portfolio of novel polycation nanomedicines to treat obesity, developed by Columbia's Dr. Kam Leong and former Columbia professor Dr. Li Qiang.
The Wall Street Journal featured a device invented by Columbia's Dr. Stavros Thomopoulos, Dr. Iden Kurtaliaj, and Dr. William Levine. The device is a a python-tooth-inspired implant to better mend rotator cuff tears.
The Columbia Lab-to-Market Accelerator Network worked alongside Empire State Development and Mount Sinai Innovation Partners to launch the 3rd round of the NYS Biodefense Commercialization Fund. Governor Hochul announced the 3rd round of awardees, including Rover Diagnostics and Dr. Ian Lipkin, who are developing technology from Columbia.